đđđĢđ¤đđ đđđŦđđđĢđđĄ đđđđĄđ¨đđ¨đĨđ¨đ đ˛ đđ¨đĢ đđĄđ đđđĢđŽ đđ§-đđĸđđĢđ¨ đđĸđđ đ§đ¨đŦđđĸđđŦ đđđĢđ¤đđ
đđĄđ đđđĢđŽ đđ§-đđĸđđĢđ¨ đđĸđđ đ§đ¨đŦđđĸđđŦ đđđĢđ¤đđ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.
đđđ˛ đđĢđ¨đ°đđĄ đđĢđĸđ¯đđĢđŦ :
đđĸđŦđĸđ§đ đđĢđđ¯đđĨđđ§đđ đ¨đ đđĄđĢđ¨đ§đĸđ đđĸđŦđđđŦđđŦ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.
đđđđĄđ§đ¨đĨđ¨đ đĸđđđĨ đđđ¯đđ§đđđĻđđ§đđŦ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.
đđĻđŠđ¨đĢđ đđĢđ¨đ°đđĄ : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.
https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
đđĄđ đđđĢđŽ đđ§-đđĸđđĢđ¨ đđĸđđ đ§đ¨đŦđđĸđđŦ đđđĢđ¤đđ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.
đđđ˛ đđĢđ¨đ°đđĄ đđĢđĸđ¯đđĢđŦ :
đđĸđŦđĸđ§đ đđĢđđ¯đđĨđđ§đđ đ¨đ đđĄđĢđ¨đ§đĸđ đđĸđŦđđđŦđđŦ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.
đđđđĄđ§đ¨đĨđ¨đ đĸđđđĨ đđđ¯đđ§đđđĻđđ§đđŦ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.
đđĻđŠđ¨đĢđ đđĢđ¨đ°đđĄ : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.
https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
đđđĢđ¤đđ đđđŦđđđĢđđĄ đđđđĄđ¨đđ¨đĨđ¨đ đ˛ đđ¨đĢ đđĄđ đđđĢđŽ đđ§-đđĸđđĢđ¨ đđĸđđ đ§đ¨đŦđđĸđđŦ đđđĢđ¤đđ
đđĄđ đđđĢđŽ đđ§-đđĸđđĢđ¨ đđĸđđ đ§đ¨đŦđđĸđđŦ đđđĢđ¤đđ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.
đđđ˛ đđĢđ¨đ°đđĄ đđĢđĸđ¯đđĢđŦ :
đđĸđŦđĸđ§đ đđĢđđ¯đđĨđđ§đđ đ¨đ đđĄđĢđ¨đ§đĸđ đđĸđŦđđđŦđđŦ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.
đđđđĄđ§đ¨đĨđ¨đ đĸđđđĨ đđđ¯đđ§đđđĻđđ§đđŦ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.
đđĻđŠđ¨đĢđ đđĢđ¨đ°đđĄ : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.
https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
0 Reacties
0 aandelen
14 Views
0 voorbeeld